SANTEN PHARMACEUTICAL CO., LTD. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.648 JPY | +0,98% |
|
+7,92% | +17,30% |
Totale waarde
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 658.032 | 742.066 | 608.810 | 490.898 | 424.342 | 593.953 | - | - |
| Bedrijfswaarde 1 | 587.236 | 662.964 | 545.395 | 406.591 | 366.439 | 559.190 | 565.264 | 545.015 |
| K/w-verhouding | 21 x | 31,4 x | 89,1 x | 18 x | -29,3 x | 21,2 x | 17,2 x | 16,5 x |
| Dividendrendement | 1,58% | 1,45% | 1,84% | 2,61% | 2,83% | 2,01% | 2,03% | 2,4% |
| Marktkapitalisatie/omzet | 2,81 x | 3,07 x | 2,44 x | 1,84 x | 1,52 x | 1,85 x | 2,02 x | 2,03 x |
| Bedrijfswaarde/omzet | 2,51 x | 2,74 x | 2,19 x | 1,53 x | 1,31 x | 1,85 x | 1,92 x | 1,86 x |
| Bedrijfswaarde/EBITDA | 10,5 x | 13,2 x | 18,4 x | 7,68 x | 25,9 x | 9,44 x | 8,84 x | 8,25 x |
| Bedrijfswaarde/FCF | 19,6 x | 19,1 x | -37,5 x | 37,4 x | 35,3 x | 23,2 x | 14,2 x | 13,1 x |
| FCF Yield | 5,1% | 5,24% | -2,67% | 2,67% | 2,83% | 4,31% | 7,05% | 7,62% |
| Price to Book | 2,26 x | 2,45 x | 1,98 x | 1,45 x | 1,44 x | 1,82 x | 1,79 x | 1,69 x |
| Aantal aandelen (in duizenden) | 399.049 | 399.390 | 399.744 | 400.080 | 375.524 | 363.942 | - | - |
| Referentieprijs 2 | 1.649 | 1.858 | 1.523 | 1.227 | 1.130 | 1.632 | 1.632 | 1.632 |
| Datum van publicatie | 9/05/19 | 8/05/20 | 11/05/21 | 10/05/22 | 11/05/23 | 9/05/24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 234.026 | 241.555 | 249.605 | 266.257 | 279.037 | 301.965 | 294.494 | 292.839 |
| EBITDA 1 | 56.067 | 50.108 | 29.685 | 52.941 | 14.159 | 63.976 | 64.558 | 65.330 |
| Bedrijfsresultaat (EBIT) 1 | 45.098 | 33.535 | 12.917 | 35.886 | -3.090 | 38.541 | 45.350 | 46.181 |
| Operationele Marge | 19,27% | 13,88% | 5,17% | 13,48% | -1,11% | 12,76% | 15,4% | 15,77% |
| Resultaat voor belastingen (EBT) 1 | 43.117 | 32.091 | 12.418 | 35.616 | -5.799 | 29.874 | 44.407 | 47.748 |
| Nettowinst (verlies) 1 | 31.954 | 23.618 | 6.830 | 27.218 | -14.948 | 26.642 | 33.420 | 35.528 |
| Nettomarge | 13,65% | 9,78% | 2,74% | 10,22% | -5,36% | 8,82% | 11,35% | 12,13% |
| WPA 2 | 78,67 | 59,16 | 17,09 | 68,07 | -38,60 | 72,59 | 93,34 | 97,36 |
| Free Cash Flow 1 | 29.959 | 34.772 | -14.547 | 10.874 | 10.370 | 26.024 | 39.863 | 41.553 |
| FCF-marge | 12,8% | 14,4% | -5,83% | 4,08% | 3,72% | 8,63% | 13,54% | 14,19% |
| Kasstroomconversie (ebitda) | 53,43% | 69,39% | - | 20,54% | 73,24% | 40,68% | 61,75% | 63,61% |
| Kasstroomconversie (nettowinst) | 93,76% | 147,23% | - | 39,95% | - | 82,04% | 119,28% | 116,96% |
| Dividend per aandeel 2 | 26,00 | 27,00 | 28,00 | 32,00 | 32,00 | 32,75 | 33,25 | 39,00 |
| Datum van publicatie | 9/05/19 | 8/05/20 | 11/05/21 | 10/05/22 | 11/05/23 | 9/05/24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: March | 2020 S1 | 2021 S1 | 2021 S2 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 | 2026 S1 | 2026 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 118.775 | 118.905 | - | 63.773 | 128.759 | 67.042 | 70.456 | - | 65.533 | 63.382 | 128.915 | 70.871 | 79.251 | 72.389 | 73.417 | 145.806 | 77.027 | 79.132 | - | 70.150 | 71.700 | 146.000 | 76.000 | 79.800 | - | 140.500 | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.743 | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 19.000 | 18.686 | - | 9.268 | 18.805 | 7.575 | 9.506 | - | 8.333 | -27.354 | -19.021 | 8.874 | 7.057 | 12.750 | 12.349 | 25.099 | 11.058 | 2.384 | - | 10.550 | 8.800 | 25.800 | 12.500 | 12.300 | - | 25.400 | - |
| Operationele Marge | 16% | 15,72% | - | 14,53% | 14,6% | 11,3% | 13,49% | - | 12,72% | -43,16% | -14,75% | 12,52% | 8,9% | 17,61% | 16,82% | 17,21% | 14,36% | 3,01% | - | 15,04% | 12,27% | 17,67% | 16,45% | 15,41% | - | 18,08% | - |
| Resultaat voor belastingen (EBT) | 18.400 | 18.353 | - | 8.841 | 18.393 | 7.280 | - | - | 9.074 | -28.177 | -19.103 | 7.510 | 5.794 | 12.868 | - | 24.075 | 9.484 | - | - | 11.900 | - | 24.700 | - | - | - | 24.300 | - |
| Nettowinst (verlies) 1 | 13.100 | 13.813 | - | 6.924 | 14.307 | 5.042 | - | - | 6.663 | -28.704 | -22.041 | 5.977 | 1.116 | 10.414 | 8.866 | 19.280 | 7.333 | 29 | - | 9.100 | - | 19.100 | - | - | - | 18.700 | - |
| Nettomarge | 11,03% | 11,62% | - | 10,86% | 11,11% | 7,52% | - | - | 10,17% | -45,29% | -17,1% | 8,43% | 1,41% | 14,39% | 12,08% | 13,22% | 9,52% | 0,04% | - | 12,97% | - | 13,08% | - | - | - | 13,31% | - |
| WPA 2 | 32,94 | 34,58 | - | 17,32 | 35,79 | 12,60 | 19,68 | - | 16,79 | -72,84 | -56,05 | 14,92 | 2,530 | 27,93 | 24,13 | 52,06 | 20,20 | 0,3300 | - | 22,32 | 18,94 | 47,80 | 27,10 | 26,51 | - | 46,80 | - |
| Dividend per aandeel 2 | 13,00 | 14,00 | 14,00 | - | 16,00 | - | - | 16,00 | - | - | 16,00 | - | - | - | 16,00 | 16,00 | - | 17,00 | 17,00 | - | 17,00 | 17,00 | - | 17,00 | 17,00 | 18,00 | 18,00 |
| Datum van publicatie | 6/11/19 | 6/11/20 | 11/05/21 | 8/11/21 | 8/11/21 | 10/02/22 | 10/05/22 | 10/05/22 | 4/08/22 | 8/11/22 | 8/11/22 | 7/02/23 | 11/05/23 | 3/08/23 | 7/11/23 | 7/11/23 | 8/02/24 | 9/05/24 | - | - | - | - | - | - | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | 10.051 | - | - |
| Nettokaspositie 1 | 70.796 | 79.102 | 63.415 | 84.307 | 57.903 | - | 28.689 | 66.425 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | 0,1571 x | - | - |
| Free Cash Flow 1 | 29.959 | 34.772 | -14.547 | 10.874 | 10.370 | 26.024 | 39.863 | 41.553 |
| ROE (netto-inkomsten/eigen vermogen) | 11,1% | 8% | 2,2% | 8,4% | -4,7% | 8,9% | 10,9% | 10,8% |
| ROA (netto-inkomsten/totale activa) | 11,1% | 8,02% | 3,06% | 8,26% | -1,32% | 6,97% | 8,19% | 7,99% |
| Totale activa 1 | 288.899 | 294.371 | 223.061 | 329.499 | 1.135.668 | 382.087 | 408.059 | 444.764 |
| Nettoactief per aandeel 2 | 729,0 | 759,0 | 770,0 | 844,0 | 783,0 | 843,0 | 907,0 | 948,0 |
| Cashflow per aandeel 2 | 106,0 | 101,0 | 59,10 | 111,0 | 5,940 | 122,0 | 153,0 | 145,0 |
| Capex 1 | 8.333 | 5.824 | 4.139 | 35.841 | 24.588 | 14.200 | 13.340 | 13.760 |
| Capex/omzet | 3,56% | 2,41% | 1,66% | 13,46% | 8,81% | 4,71% | 4,53% | 4,7% |
| Datum van publicatie | 9/05/19 | 8/05/20 | 11/05/21 | 10/05/22 | 11/05/23 | 9/05/24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B+
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
10
Laatste slotkoers
1.632
JPY
Gemiddelde koersdoel
1.787
JPY
Spread / Gemiddelde doel
+9,50%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +17,30% | 3,81 mld. | |
| +30,38% | 684 mld. | |
| +29,49% | 568 mld. | |
| -4,36% | 361 mld. | |
| +19,30% | 329 mld. | |
| +3,73% | 284 mld. | |
| +16,08% | 240 mld. | |
| +9,25% | 208 mld. | |
| -7,28% | 200 mld. | |
| +7,68% | 166 mld. |
- Beurs
- Aandelen
- Koers 4536
- Financiën Santen Pharmaceutical Co., Ltd.
